Fresenius SE & Co. KGaA
FSNUY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$116.07B
Close$
$0.94
92.7% downside
Current Fair Value
92.7% downsideOvervalued by 92.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $116.07 Billion |
|---|---|
| Enterprise Value | $126.21 Billion |
| Annual dividend | $0.30 |
| Dividend yield | 2.28% |
| Earnings per Share | $0.14 |
| Beta | 0.83 |
| Outstanding Shares | 9,011,796,432 |
Return
| Return on Equity | 7.78% |
|---|---|
| Return on Assets | 3.66% |
| Return on Invested Capital | 6.99% |
Valuation & Multiples
| P/E Ratio | 16.76 |
|---|---|
| PEG | 94.85 |
| Price to Sales | 6.42 |
| Price to Book Ratio | 6.42 |
| Enterprise Value to Revenue | 5.36 |
| Enterprise Value to EBIT | 55.1 |
| Enterprise Value to Net Income | 82 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.25
Consensus analyst estimateRevenue Estimate
$6.65 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.22
Consensus analyst estimateRevenue Estimate
$6.51 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Fresenius SE & Co. KGaA
178,486 employees
CEO: Michael Sen
Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. Its activities are structured ...